HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Davis, H Articles by Moore, R M Search for Related Content PubMed PubMed Citation Articles by Davis, H Articles by Moore, R M, Jr

National trends in the mortality of children with sickle cell disease, 1968 through 1992.

H Davis, K C Schoendorf, P J Gergen and R M Moore, Jr

Office of International and Refugee Health, US Department of Health and Human Services, Rockville, Md, USA.

OBJECTIVES: This paper describes national trends in mortality of children with sickle cell disease and the settings in which death occurred. METHODS: United States death certificate data from 1968 through 1992 were used to calculate mortality rates of Black children with sickle cell disease 1 to 14 years old. Deaths from trauma, congenital anomalies, and perinatal conditions were excluded. RESULTS: Between 1968 and 1992, mortality rates of Black children with sickle cell disease decreased 41% for 1- to 4-year-olds, 47% for 5- to 9-year-olds, and 53% for 10- to 14-year-olds. During 1986 through 1992, children who died before hospital admission accounted for 41% of deaths among 1- to 4-year-olds, 27% among 5- to 9-year-olds, and 12% among 10- to 14-year-olds. CONCLUSIONS: Survival of Black children with sickle cell disease has improved markedly since 1968. A substantial proportion of deaths continue to occur prior to hospital admission. Trends in sickle cell mortality can be monitored inexpensively with death-certificate data.

This article has been cited by other articles:

				C. T. Quinn, Z. R. Rogers, and G. R. Buchanan Survival of children with sickle cell disease Blood, June 1, 2004; 103(11): 4023 - 4027. [Abstract] [Full Text] [PDF]

				D. M. Wilson, H. C. Northcott, C. D. Truman, S. L. Smith, M. C. Anderson, R. L. Fainsinger, and M. J. Stingl Location of Death in Canada: A Comparison of 20th-Century Hospital and Nonhospital Locations of Death and Corresponding Population Trends Eval Health Prof, December 1, 2001; 24(4): 385 - 403. [Abstract] [PDF]

				G. J. Lonergan, D. B. Cline, and S. L. Abbondanzo Sickle Cell Anemia RadioGraphics, July 1, 2001; 21(4): 971 - 994. [Abstract] [Full Text] [PDF]

				K. L. O'Brien, A. J. Swift, J. A. Winkelstein, M. Santosham, B. Stover, R. Luddy, J. E. Gootenberg, J. T. Nold, A. Eskenazi, S. J. Snader, et al. Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 Among Infants With Sickle Cell Disease Pediatrics, November 1, 2000; 106(5): 965 - 972. [Abstract] [Full Text]